A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...
Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...
A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...
Two new analyses, one from France and one from China, suggest that seasonal influenza vaccination provided moderate protection during the early months of the 2025–26 flu season, despite the rapid ...
Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a new approach to the development of COVID-19 vaccines and monoclonal antibodies (mAbs) to restore public trust in health ...
A total of 22 mRNA vaccine development contracts totaling roughly $500 million have been canceled, the Department of Health and Human Services (HHS) announced Tuesday. The mRNA investments were part ...
The new foot-and-mouth disease vaccine developed by researchers at Diamond Light Source is projected to deliver over $1.3 ...
A future ASF vaccination program must be accompanied by an accurate way to distinguish vaccinated animals from those ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback